Aptus Capital Advisors, LLC Eli Lilly & CO Transaction History

Aptus Capital Advisors, LLC

$6.27 Billion
Q3 2024

A detailed history of Aptus Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 35,477 shares of LLY stock, worth $28.2 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

35,477

Previous 30,297 17.1%

Holding current value

$28.2 Million

Previous $27.4 Million 14.58%

% of portfolio

0.5%

Previous 0.52%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $4 Million - $4.97 Million	5,180 Added 17.1%	35,477 $31.4 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $3.95 Million - $4.96 Million	5,454 Added 21.95%	30,297 $27.4 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $887,115 - $1.19 Million	1,498 Added 6.42%	24,843 $19.3 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $12,079 - $14,239	-23 Reduced 0.1%	23,345 $13.6 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $489,472 - $674,811	-1,126 Reduced 4.6%	23,368 $12.6 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $1.87 Million - $2.5 Million	-5,327 Reduced 17.86%	24,494 $11.5 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $1.45 Million - $1.7 Million	-4,660 Reduced 13.51%	29,821 $10.2 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $243,413 - $283,625	757 Added 2.24%	34,481 $12.6 Million
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $2.55 Million - $2.91 Million	8,609 Added 34.28%	33,724 $10.9 Million
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $2.79 Million - $3.28 Million	10,017 Added 66.35%	25,115 $8.14 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $610,194 - $758,316	2,600 Added 20.8%	15,098 $4.32 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $347,168 - $430,837	1,544 Added 14.1%	12,498 $3.45 Million
Q3 2021 Oct 27, 2021	BUY	$221.6 - $272.71 $195,451 - $240,530	882 Added 8.76%	10,954 $2.53 Million
Q2 2021 Jul 27, 2021	BUY	$180.55 - $233.54 $499,762 - $646,438	2,768 Added 37.9%	10,072 $2.31 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $141,808 - $183,577	-863 Reduced 10.57%	7,304 $1.36 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $82,320 - $108,929	631 Added 8.37%	8,167 $1.38 Million
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $2.13 Million - $2.47 Million	-14,591 Reduced 65.94%	7,536 $1.12 Million
Q2 2020 Jul 22, 2020	BUY	$136.42 - $164.18 $788,507 - $948,960	5,780 Added 35.36%	22,127 $3.63 Million
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $1.67 Million - $2.07 Million	14,024 Added 603.7%	16,347 $2.27 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $23,201 - $28,737	217 Added 10.3%	2,323 $305,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $234,418 - $275,928	2,106 New	2,106 $273,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Account

Aptus Capital Advisors, LLC Eli Lilly & CO Transaction History